STOCK TITAN

GE HealthCare Technologies (GEHC) 10-K Filings

GEHC NASDAQ

Here are the 10-K annual reports from GE HealthCare Technologies Inc. (GEHC) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-K covers the audited annual report, with the full financial statements, so if you follow GEHC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GEHC filings page.

Rhea-AI Summary

GE HealthCare Technologies Inc. files its annual report describing its 2025 performance, business structure, and key risks. The company is a global healthcare solutions provider focused on advanced medical technology, pharmaceutical diagnostics, and AI-, cloud- and software-based tools for clinicians.

GE HealthCare operates four segments: Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics, serving hospitals and health systems in over 160 countries. The business combines large installed equipment, recurring consumables, service contracts, and digital solutions, and notes that fourth-quarter results are typically stronger due to customer spending patterns.

The company, spun off from General Electric in January 2023, reports approximately 54,000 employees, including 11,100 engineers and scientists and extensive global sales and service networks. As of June 30, 2025, non‑affiliate shareholders held common stock with an aggregate market value of about $34 billion, and 455,749,767 shares were outstanding as of January 28, 2026. The report highlights extensive regulatory, cybersecurity, competition, reimbursement, geopolitical, and data‑privacy risks that could affect future results.